Farricielli Joseph J. Jr. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
15
Insider Buys Sum
$24,775.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Farricielli Joseph J. Jr.

Biography of Farricielli Joseph J. Jr.

No biography is available at this moment.

2009-06-15PurchaseEterna Therapeutics Inc.
ERNA
director
10,000
0.0192%
$0.42$4,200+31.71%
2009-06-04PurchaseEterna Therapeutics Inc.
ERNA
director
1,300
0.0024%
$0.41$533+31.71%
2009-06-01PurchaseEterna Therapeutics Inc.
ERNA
director
2,700
0.0045%
$0.36$972+42.11%
2009-05-19PurchaseEterna Therapeutics Inc.
ERNA
director
20,000
0.0357%
$0.39$7,800+38.46%
2008-12-16PurchaseEterna Therapeutics Inc.
ERNA
director
10,000
0.005%
$0.11$1,100+104.17%
2008-12-04PurchaseEterna Therapeutics Inc.
ERNA
director
10,000
0.005%
$0.11$1,100+122.73%
2008-12-03PurchaseEterna Therapeutics Inc.
ERNA
director
10,000
0.006%
$0.13$1,300+88.46%
2008-12-02PurchaseEterna Therapeutics Inc.
ERNA
director
300
0.0002%
$0.14$42+88.46%
2008-12-01PurchaseEterna Therapeutics Inc.
ERNA
director
8,700
0.0056%
$0.14$1,218+53.13%
2008-11-28PurchaseEterna Therapeutics Inc.
ERNA
director
1,000
0.0006%
$0.14$140+44.12%
2008-11-12PurchaseEterna Therapeutics Inc.
ERNA
director
5,000
0.003%
$0.13$650+63.33%
2008-11-11PurchaseEterna Therapeutics Inc.
ERNA
director
15,000
0.0096%
$0.14$2,100+75%
2008-09-16PurchaseEterna Therapeutics Inc.
ERNA
director
10,000
0.0096%
$0.21$2,100-15.91%
2008-09-11PurchaseEterna Therapeutics Inc.
ERNA
director
1,000
0.001%
$0.22$220-15.91%
2008-09-10PurchaseEterna Therapeutics Inc.
ERNA
director
5,000
0.006%
$0.26$1,300-19.57%
Total: 15
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.